Ki‐67 index, progesterone receptor expression, histologic grade and tumor size in predicting breast cancer recurrence risk: A consecutive cohort study

BACKGROUND: The 21‐gene recurrence score (RS) assay has been recommended by major guidelines for treatment decision in hormone receptor (HR)‐positive early breast cancer (EBC). However, the genomic assay is not accessible and affordable worldwide. Alternatively, an increasing number of studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanna, Zhou, Yidong, Mao, Feng, Yao, Ru, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170660/
https://www.ncbi.nlm.nih.gov/pubmed/32291973
http://dx.doi.org/10.1002/cac2.12024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170660/
https://www.ncbi.nlm.nih.gov/pubmed/32291973
http://dx.doi.org/10.1002/cac2.12024

Ejemplares similares